All companies
Visit website
Health Care Originals
OperatingHealth Care Originals, Inc.
Healthcare · Founded 2016
AI-powered respiratory care for asthma & copd patients
Post-money valuation ⓘ
$13.0M
As of Jul 2025 · from HEALTH CARE ORIGINALS Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$0
Across 1 round since 2024
Latest share price
$1.52
HEALTH CARE ORIGINALS Preferred Stock 1 offering price
Financials
FY2022–FY2025 · from SEC filings · hover any figure for its source$8K
−$3.3M
2022
$5K
−$2.7M
2023
$5K
−$2.7M
2024
$14K
−$2.3M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$7,687
$5,051
$5,051
$13,878
Cost of goods sold
$13,712
$5,439
$5,439
$0
Gross margin
-78%
-8%
-8%
100%
Net income
-$3,323,424
-$2,650,362
-$2,650,362
-$2,315,617
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$7,256
$576,962
$576,962
$544,546
Accounts receivable
$0
$3,746
$3,746
$0
Total assets
$402,586
$1,014,947
$1,014,947
$914,511
Short-term debt
$174,318
$179,166
$179,166
$481,998
Long-term debt
$6,591,383
$1,307,945
$1,307,945
$1,532,945
Total liabilities
$6,765,701
$1,487,111
$1,487,111
$2,014,943
Other
Headcount
—
7
—
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$13.0M
post-money
HEALTH CARE ORIGINALS Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised — / $1.2MPost-money $13M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0002037345Share price $1.52
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.